UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000004440
Receipt number R000005298
Scientific Title A phase ll study to show the feasibility of six months continuous administration of Docetaxel+TS-1 for patients with Stage lllA/lllB gastric cancer after surgical resection (OGSG 1002)
Date of disclosure of the study information 2010/11/01
Last modified on 2022/11/06 12:23:44

No. Disposal Last modified on Item of update
1 Insert 2010/10/25 17:17:57
2 Update 2011/03/04 17:24:17 Recruitment status
Anticipated trial start date
Last follow-up date
3 Update 2011/11/22 19:12:01 Organization
Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2011/11/30 17:54:22 Last follow-up date
5 Update 2012/06/24 23:03:03 Public title
Public title
Acronym
Acronym
6 Update 2012/06/24 23:06:17 Organization
Organization
Division name
Division name
Address
Address
TEL
Organization
Organization
Division name
Address
Address
TEL
Email
Organization1
Address1
Tel1
Email1
7 Update 2013/04/26 21:21:53 Recruitment status
Last follow-up date
8 Update 2013/05/28 21:34:31 Anticipated trial start date
Last follow-up date
9 Update 2014/07/27 22:18:07 Organization
Organization
Address
Address
TEL
Email
Email
Institutions
10 Update 2014/07/27 22:31:01 Last follow-up date
Date analysis concluded
11 Update 2014/07/27 22:32:05 Last follow-up date
Date analysis concluded
12 Update 2014/07/27 22:41:16 Institutions
13 Update 2014/07/27 23:11:52 Institutions
14 Update 2015/05/28 00:05:41 Email
Email
15 Update 2018/05/10 20:24:54 Email
Email
Name of primary person or sponsor
Organization
16 Update 2018/08/02 21:46:08 UMIN ID1
17 Update 2018/08/02 21:48:18 Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Institute
18 Update 2018/10/30 21:30:49 Recruitment status
Last follow-up date
Date analysis concluded
19 Update 2020/01/05 13:43:10 Date of IRB
Date analysis concluded
20 Update 2020/01/22 21:28:02 Date of IRB
21 Update 2022/11/06 12:23:44 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures